Table 1.
Characteristics of whole ACS patients undergoing stent implantation and with or without DM.
| Variable | Whole (n = 437) | Non-DM (n = 294) | DM (n = 143) | P value |
|---|---|---|---|---|
| Mean corpuscular volume, fl | 93.30 (90.25-96.35) | 94.05 (90.80-97.50) | 91.30 (88.40-94.60) | <0.001 |
| Age, years | 60.35 ± 10.27 | 59.08 ± 10.24 | 63.02 ± 9.92 | 0.002 |
| Sex | ||||
| Male, % | 340 (77.8) | 237 (80.6) | 103 (72.3) | 0.060 |
| Body mass index, kg/m2 | 25.00 ± 3.26 | 25.05 ± 3.35 | 24.99 ± 3.23 | 0.558 |
| Smoking, % | 246 (56.3) | 170 (57.8) | 76 (53.1) | 0.411 |
| Past MI, % | 67 (15.3) | 50 (17.0) | 17 (11.9) | 0.211 |
| Past PCI or CABG, % | 85 (19.5) | 59 (20.1) | 26 (18.2) | 0.735 |
| Hypertension, % | 227 (51.9) | 148 (50.3) | 79 (55.2) | 0.389 |
| Family history, % | 176 (40.1) | 125 (42.5) | 51 (35.7) | 0.205 |
| Diastolic blood pressure, mmHg | 80 (70-84) | 80 (70-84) | 80 (70-84) | 0.934 |
| Systolic blood pressure, mmHg | 120 (114-140) | 120 (112-140) | 127 (114-140) | 0.281 |
| Heart rate, bmp | 69 (61-78) | 69 (61-78) | 70 (62-77) | 0.982 |
| Hemoglobin A1c, % | 6.00 (5.60-6.70) | 5.70 (5.50-6.00) | 7.40 (6.60-8.80) | <0.001 |
| Left ventricle ejection fraction, % | 61 (49-68) | 62 (49-68) | 59 (45-68) | 0.117 |
| Hemoglobin, g/L | 140.00 (128.00-151.00) | 141.00 (129.50-151.00) | 137.00 (123.00-149.00) | 0.032 |
| Platelet, 103 cells/dL | 181.00 (147.00-217.00) | 183.50 (149.70-224.00) | 176.00 (140.00-205.00) | 0.055 |
| Creatinine, mg/dL | 66.71 (58.27-77.37) | 67.38 (58.66-77.40) | 64.74 (56.04-77.37) | 0.527 |
| Triglycerides, mmol/L | 1.42 (1.08-1.96) | 1.42 (1.09-1.94) | 1.42 (1.00-1.98) | 0.854 |
| High-density lipoprotein, mmol/L | 0.87 (0.76-1.03) | 0.89 (0.76-1.06) | 0.84 (0.74-0.99) | 0.134 |
| Low-density lipoprotein, mmol/L | 2.13 (1.63-2.68) | 2.18 (1.65-2.73) | 2.04 (1.56-2.59) | 0.128 |
| Apolipoprotein A1, g/L | 1.05 (0.96-1.19) | 1.05 (0.96-1.19) | 1.05 (0.94-1.19 | 0.678 |
| High-sensitivity C-reactive protein, mg/L | 1.40 (0.74-3.50) | 1.46 (0.76-3.61) | 1.19 (0.64-2.99) | 0.375 |
| Creatine kinase isoenzymes MB, U/L | 15.70 (11.44-32.33) | 15.70 (11.30-35.60) | 15.75 (12.10-26.50) | 0.864 |
| Pro-B-type natriuretic peptide, pg/mL | 377.45 (122.86-1008.50) | 377.45 (122.18-1003.50) | 377.80 (135.86-1063.25) | 0.924 |
| Medicine at discharge, % | ||||
| Aspirin | 433 (99.1) | 291 (99.0) | 142 (99.3) | a |
| Clopidogrel | 425 (97.3) | 285 (96.9) | 140 (97.9) | 0.679 |
| ACEI/ARB | 398 (91.1) | 269 (91.5) | 129 (90.2) | 0.792 |
| Calcium channel blocker | 95 (21.7) | 60 (20.4) | 35 (24.5) | 0.399 |
| β-Blockers | 385 (88.1) | 262 (89.1) | 123 (86.0) | 0.434 |
| Statin | 429 (98.2) | 289 (98.3) | 140 (97.9) | a |
Data are presented as mean ± SD, median (IQR) or number (%), “a” represents P value = 1. ACS: acute coronary syndrome; DM: diabetes mellitus; MI: myocardial infarction; PCI or CABG: past percutaneous coronary intervention or coronary artery bypass grafting; ACEI: angiotensin-converting enzyme inhibition; ARB: angiotensin receptor blocker.